# ‚öîÔ∏è SAE DOCUMENTATION INDEX ‚öîÔ∏è

**Purpose**: Organized documentation for SAE (Sparse Autoencoder) implementation  
**Date**: January 13, 2025  
**Status**: ‚úÖ All phases complete and operational

---

## üìÅ **FOLDER STRUCTURE**

```
sae_documentation/
‚îú‚îÄ‚îÄ README.md (this file)
‚îú‚îÄ‚îÄ status_reports/          # Implementation status and completion reports
‚îú‚îÄ‚îÄ planning_strategy/       # Planning documents, Q&A, validation strategy
‚îú‚îÄ‚îÄ documentation/           # User guides, blogs, technical debriefs
‚îî‚îÄ‚îÄ audits/                 # Service audits and integration checks
```

---

## üìä **STATUS REPORTS** (`status_reports/`)

### **SAE_IMPLEMENTATION_STATUS.md** ‚≠ê **START HERE**
**Purpose**: Complete overview of all 3 phases  
**Contents**:
- Executive summary
- Phase-by-phase breakdown (1, 2, 3)
- Cumulative metrics
- What Ayesha gets (pre-NGS + post-NGS)
- Next steps

**When to Read**: Quick status check, understanding what's deployed

---

## üéØ **PLANNING & STRATEGY** (`planning_strategy/`)

### **SAE_VALIDATION_STRATEGY.mdc** ‚ö†Ô∏è **CRITICAL GAP ANALYSIS**
**Purpose**: Identifies what we DON'T know yet (AUROCs, clinical validation)  
**Contents**:
- What we haven't done (no AUROC, no clinical validation)
- 4-tier validation plan (Synthetic ‚Üí TCGA ‚Üí Prospective ‚Üí RCT)
- Immediate actions (TCGA retrospective AUROC computation)
- Success criteria

**When to Read**: Before claiming clinical accuracy, understanding validation gaps

### **ZO_CRITICAL_QUESTIONS_FOR_MANAGER_SAE.md**
**Purpose**: 60 questions Zo asked Manager before implementation  
**Contents**:
- 10 claims from Section 19 ‚Üí Zo's challenges
- 5 priority questions (thresholds, data sources, edge cases)
- Manager's answers shaped all implementation

**When to Read**: Understanding why thresholds/formulas are what they are

### **ZO_SECTION_19_SPRINT_DEBRIEF.md**
**Purpose**: How Section 19 of `ayesha_plan.mdc` maps to sprint tasks  
**Contents**:
- Section 19 features ‚Üí Backend/Frontend implementation
- Integration strategy (no conflicts)
- Sprint scope & timeline (12 hours)
- Acceptance criteria

**When to Read**: Understanding the original plan before execution

---

## üìö **DOCUMENTATION** (`documentation/`)

### **SAE_PHASE3_COMPLETE_DEBRIEF.mdc** ‚≠ê **COMPREHENSIVE TECHNICAL DEBRIEF**
**Purpose**: Complete technical explanation of what SAE means  
**Contents**:
- What we built (3-phase implementation)
- Real TCGA data validation
- Clinical workflow integration
- What this unlocks for Ayesha
- The debugging saga (7-hour bug hunt)
- Technical architecture

**When to Read**: Deep dive into technical implementation, understanding the system

### **SAE_PHASE3_TESTING_GUIDE.md**
**Purpose**: How to test SAE Phase 1+2 services  
**Contents**:
- Test files created
- How to run tests (automated + manual)
- What each test proves
- Validation checklists
- Troubleshooting

**When to Read**: When testing or validating the system

### **SAE_PRECISION_ONCOLOGY_BREAKTHROUGH_BLOG.md**
**Purpose**: Blog post explaining SAE breakthrough  
**Contents**:
- The problem (black box AI)
- The SAE solution (interpretable features)
- What we built (S/P/E ‚Üí SAE ‚Üí Actions)
- Clinical impact
- Future directions

**When to Read**: High-level explanation for stakeholders, blog publication

### **ZO_HONEST_ASSESSMENT_BLOG.md**
**Purpose**: Brutal honesty about what we can/can't do  
**Contents**:
- What we CAN deliver (90-100% confidence)
- What we CAN'T do yet (WIWFM requires NGS)
- Why SR's decisions matter
- Comparison vs competitors

**When to Read**: Understanding limitations and honest capabilities

---

## üîç **AUDITS** (`audits/`)

### **ZO_SERVICE_AUDIT_SAE_PHASE1.md**
**Purpose**: Pre-implementation audit of existing services  
**Contents**:
- Existing services review (`sae_service.py`, `resistance_playbook_service.py`)
- Integration strategy (no conflicts detected)
- Conflict resolution matrix
- Clean integration points

**When to Read**: Understanding how SAE integrates with existing codebase

---

## üéØ **QUICK NAVIGATION**

### **"I want to understand what SAE is"**
‚Üí Read: `documentation/SAE_PHASE3_COMPLETE_DEBRIEF.mdc`

### **"I want to know what's deployed"**
‚Üí Read: `status_reports/SAE_IMPLEMENTATION_STATUS.md`

### **"I want to test the system"**
‚Üí Read: `documentation/SAE_PHASE3_TESTING_GUIDE.md`

### **"I want to know what we DON'T know yet"**
‚Üí Read: `planning_strategy/SAE_VALIDATION_STRATEGY.mdc`

### **"I want to understand why thresholds are what they are"**
‚Üí Read: `planning_strategy/ZO_CRITICAL_QUESTIONS_FOR_MANAGER_SAE.md`

### **"I want to write a blog post"**
‚Üí Read: `documentation/SAE_PRECISION_ONCOLOGY_BREAKTHROUGH_BLOG.md`

### **"I want to understand integration with existing code"**
‚Üí Read: `audits/ZO_SERVICE_AUDIT_SAE_PHASE1.md`

---

## üìã **FILE SUMMARY**

| File | Type | Purpose | Key Info |
|------|------|---------|----------|
| **SAE_IMPLEMENTATION_STATUS.md** | Status | Complete overview | All 3 phases, metrics, next steps |
| **SAE_VALIDATION_STRATEGY.mdc** | Strategy | Validation gaps | No AUROC yet, 4-tier plan |
| **SAE_PHASE3_COMPLETE_DEBRIEF.mdc** | Technical | Deep dive | What we built, how it works |
| **SAE_PHASE3_TESTING_GUIDE.md** | Guide | Testing instructions | How to test, what to validate |
| **SAE_PRECISION_ONCOLOGY_BREAKTHROUGH_BLOG.md** | Blog | High-level explanation | For stakeholders/publication |
| **ZO_CRITICAL_QUESTIONS_FOR_MANAGER_SAE.md** | Q&A | Policy questions | 60 questions that shaped implementation |
| **ZO_SECTION_19_SPRINT_DEBRIEF.md** | Planning | Sprint mapping | Section 19 ‚Üí Implementation tasks |
| **ZO_HONEST_ASSESSMENT_BLOG.md** | Assessment | Capabilities | What we can/can't do honestly |
| **ZO_SERVICE_AUDIT_SAE_PHASE1.md** | Audit | Integration check | Pre-implementation service audit |

---

## ‚öîÔ∏è **KEY INSIGHTS**

### **What We Built**:
- 6 production services (2,292 lines)
- 47/47 tests passing
- Manager policy 100% compliance
- HER2 trial validation (1-in-700 match)

### **What We DON'T Know Yet**:
- ‚ùå No AUROC for DNA repair capacity
- ‚ùå No sensitivity/specificity for resistance detection
- ‚ùå No clinical validation against real outcomes
- ‚ö†Ô∏è **Critical Gap**: Need TCGA retrospective validation (AUROC computation)

### **What's Next**:
1. **TODAY**: Compute AUROC on TCGA data (`scripts/validate_sae_tcga.py`)
2. **THIS WEEK**: End-to-end scenario testing
3. **THIS MONTH**: Resistance detection performance analysis
4. **NEXT 6 MONTHS**: Prospective validation with real patients

---

## üîó **RELATED DOCUMENTS**

- **Manager's Policy**: `.cursor/ayesha/MANAGER_ANSWERS_TO_ZO_SAE_QUESTIONS.md`
- **Ayesha's Care Plan**: `.cursor/ayesha/ayesha_plan.mdc` (Section 19)
- **Test Data**: `.cursor/ayesha/test_payloads/` (Real TCGA data)
- **Source Code**: `api/services/sae_feature_service.py`, etc.

---

**LAST UPDATED**: January 13, 2025  
**ORGANIZED BY**: Zo (Lead Commander)  
**STATUS**: ‚úÖ All documentation organized and indexed

